HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- hydroxy- 6- (4- carbamoylacridinyl)hexanamide

a histone deacetylase inhibitor; structure in first source

Also Known As:

WJ35435

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Acridines: 325
      - N-hydroxy-6-(4-carbamoylacridinyl)hexanamide: 1
Organic Chemicals: 133
- Amines: 4871
  - Hydroxylamines: 16
    - Hydroxamic Acids: 239
      - N-hydroxy-6-(4-carbamoylacridinyl)hexanamide: 1
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Hydroxamic Acids: 239
      - N-hydroxy-6-(4-carbamoylacridinyl)hexanamide: 1

Experts

1.	Chao, Shi-Wei: 1 article (08/2014)
2.	Guh, Jih-Hwa: 1 article (08/2014)
3.	Hsu, Jui-Ling: 1 article (08/2014)
4.	Huang, Wei-Jan: 1 article (08/2014)
5.	Li, Tsia-Kun: 1 article (08/2014)
6.	Liu, Shih-Ping: 1 article (08/2014)
7.	Pan, Shiow-Lin: 1 article (08/2014)
8.	Yang, Yu-Chen: 1 article (08/2014)
9.	Yu, Chia-Chun: 1 article (08/2014)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 08/01/2014 - "WJ35435 showed better potency than vorinostat and DACA against PC-3 and DU-145, two human hormone-refractory metastatic prostate cancer (HRMPC) cell lines, but not benign prostate cells. "

Related Drugs and Biologics

1.	Hormones (Hormone)
2.	Vorinostat